View Press Releases
-
Vyasa Introduces Cortex: Intuitive, Visual Data Fabric Creation & Management
Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest application, Cortex. An intuitive data management tool, Cortex acts as the “blueprint” of the data fabric by allowing users to build, manage and provision access to data sources connected to Vyasa Layar data fabrics.
Mar 9, 2022
-
Emmes Acquires Casimir, Its Fourth Major Acquisition
-
Japan tops CPhI ‘API Quality’ ranking for second year
-
Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients
-
Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children
-
mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index
Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.
Feb 13, 2022
-
mdgroup Appoints Steph Katz as Director of Seacole Health
mdgroup Appoints Steph Katz as Director of Seacole Health Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.
Feb 14, 2022
-
PubHive Unveils New Dashboard for Systematic Review SaaS Solution
AI-powered cloud software platform PubHive Navigator now features a new user dashboard that speeds up systematic literature review workflows for PubHive users
Feb 15, 2022
-
Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board
Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
Feb 15, 2022
-
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
Feb 15, 2022
-
New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to enterprise-level
Watson-Marlow Fluid Technology Group (WMFTG) is extending its industrial Ethernet control offer by making PROFINET available on its 530, 630 and 730 series of cased peristaltic pumps. This additional communication capability allows customers to access fast, accurate performance data and seamless connectivity with modern PLC control systems and the Internet of Things (IoT) using either EtherNet/IP™ or PROFINET®.
Feb 15, 2022
-
University of Miami Medical Researchers Accelerate Future of Personalized Wellness with the MILBox Project
Researchers at the University of Miami have unveiled a groundbreaking research project called the MILBox, which uses AI to create “digital twins” of patients. Once created, healthcare practitioners can test and evaluate various treatment options and potential outcomes on these “digital twins,” before applying them in the physical world. The study is supported by Amazon Web Services and Open Health Network, which use data from wearables and in-home sensors to create these “digital twins."
Feb 15, 2022
-
QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM
-
MetaboParis-Santé platform first in France to install Bruker In Vitro Diagnostic research by NMR* system at Université de Paris
Université de Paris has installed new Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform located in the center of Paris city, France.
Jan 25, 2022
-
Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s
Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, and Domainex Ltd., today announce a collaboration focused on developing small molecule therapies targeting neuroinflammation that could slow the progression of Parkinson’s.
Feb 2, 2022
-
Science 37® and PhysIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use remote biosensors and machine learning to build more robust data sets. This will help increase the number of digital biomarkers and generate insights from continuous data streams to more quickly and objectively demonstrate the safety and efficacy of treatments.
Feb 2, 2022
-
mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022
‘Double Agent’ in Healthcare Industry Will Promote a Truly Patient-Centric Agenda Bracknell, UK - 3 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for remote patient visits improves data integrity and monitoring. He will be sharing how the latest medical technologies meet patient care to create remarkable patient experiences, and the important factors to consider when selecting Healthcare Professionals for mobile health patient visits.
Feb 3, 2022
-
Qlucore appoints new Head of R&D
Qlucore appoints new Head of R&D
Feb 6, 2022
-
Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care
Leading Digital Health Company Expands Provider and Payer Customer Base as Demand for Patient Access Solutions Accelerates Across the Healthcare Industry
Feb 6, 2022
-
DFE Pharma appoints Martti Hedman as new CEO
DFE Pharma appoints Martti Hedman as new CEO The combination of his experience, culture and drive makes him an ideal fit for DFE Pharma for the next stages of growth Goch, Germany (7th February 2022) – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, today announced that Martti Hedman has been appointed as the new Chief Executive Officer. An experienced business leader, Hedman will succeed Bas van Driel and assume responsibilities on 14th February. Van Driel decided to step down in order to allow the company to further grow after setting the company up for success.
Feb 6, 2022